Chronic Brain Damage Management Market

Chronic brain damage management sales will grow through 2036, led by imaging studies at 42.6% of the diagnosis segment in 2026. The market was valued at USD 1.06 billion in 2025 and is expected to be worth USD 2.17 billion by 2036, creating an incremental opportunity of USD 1.07 billion.